2016 annual financial data
Vistagen Therapeutics 2016 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,850,200 USD and net income was -47,220,500 USD.
Operating cash flow was -4,808,500 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,850,200 USD
- Net income
- -47,220,500 USD
- Operating cash flow
- -4,808,500 USD